soticlestat experimental anticonvulsant cholesterol inhibitor investigated treatment dravet syndrome syndrome tuberous sclerosis complex syndrome deficiency development rights drug purchased takeda pharmaceuticals ovid therapeutics soticlestat designated orphan drug fda treatment dravet syndrome phase study called elektra soticlestat well tolerated reduced seizure frequency patients dravet syndrome soticlestat functions blocking cholesterol also known enzyme brain converts cholesterol oxysterol reduction shown reduce glutamatergic signaling reduces soticlestat may also neuroprotective antiinflammatory properties via glial cell httpsenwikipediaorgwikisoticlestat